DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Medivation
Medivation
Critical Analysis of Valuation and Strategical Orientation of Merger
Radium-223 in Combination with Docetaxel in Patients with Castration
Summary Conflict of Interest Statements BCC 2021
The Veeda Newsletter
Trends in Oncology Business Development
Disclosure Summary
Sanofi Could Pursue Other Oncology M&A Targets After Medivation Loss
Medivation, Inc
2016 Pharma Dealmaking
Medivation: No to Sanofi's Renewed Press to Take $9.3B Offer 5 May 2016, by by Linda A
Appendix a 2017 Financial Report Financial Review Pfizer Inc
Bloomberg Intelligence Primers
Race-Related Germline Polymorphisms in Key Androgen
United States Securities and Exchange Commission Washington, D.C
Pfizer Wins Over Medivation with $14B Buyout by Chelsea Naso
First 500 Patients of IRONMAN: International Registry for Men with Advanced Prostate Cancer
A Phase II Study of Talazoparib After Platinum Or Cytotoxic Nonplatinum
On Site: Pfizer to Acquire Medivation for $14 Billion As Oncology Deals Continue to Rise
Top View
Volunteer Disclosure Report
2019 Cancer Communications Committee
EXECUTIVE COMMITTEE MEMBERS, DEPARTMENT/PROGRAMME COORDINATORS and SCIENTIFIC COMMITTEE MEMBERS